Aprea Therapeutics APRE Income Statement (2018-2026)

NASDAQ APRE
$0.63 -0.04 (-5.69%)
As of: Aug 20, 2026 · 3:57 PM EDT
Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
6.02M4.46M4.09M6.81M1.12M0.53M1.26M2.20M2.12M2.05M1.60M2.56M2.85M2.36M2.48M1.91M1.64M1.01M1.61M2.46M
Selling, General & Administrative (Quarter)
3.41M3.37M3.99M15.63M3.08M2.12M3.37M1.70M1.72M1.64M1.93M1.85M1.61M1.07M1.76M1.59M1.48M1.64M1.82M1.57M
Other Operating Expenses (Quarter)
76.02M
Operating Expenses (Quarter)
9.43M7.83M8.07M98.47M4.20M2.65M4.62M3.90M3.84M3.69M3.53M4.41M4.45M3.43M4.25M3.51M3.12M2.65M3.43M4.03M
Operating Income (Quarter)
-98.47M-4.20M-2.65M-4.62M-3.65M-3.52M-3.67M-3.15M-3.85M-4.10M-3.23M-4.09M-3.39M-3.12M-2.64M-3.43M-4.03M
EBIT (Quarter)
-98.47M-4.20M-2.65M-4.62M-3.65M-3.52M-3.67M-3.15M-3.85M-4.10M-3.23M-4.09M-3.39M-3.12M-2.64M-3.43M-4.03M
Non-operating items
Other Non Operating Income (Quarter)
-0.02M0.07M0.14M0.15M0.02M-0.03M-0.01M0.39M0.32M1.15M0.34M-0.01M0.31M0.33M0.15M0.15M-0.01M0.72M0.01M0.44M
Non Operating Income (Quarter)
-33.000.00M0.00M0.05M0.15M0.24M0.26M0.34M0.32M0.31M0.28M0.38M0.35M0.27M0.20M0.18M0.15M0.12M0.13M0.36M
Net income details
EBT (Quarter)
-98.53M-4.19M-2.78M-4.62M-3.65M-3.52M-53.12M-3.15M-3.85M-4.10M-53.39M-4.09M-3.39M-3.12M-58.99M-3.43M-4.03M
Profit After Tax (Quarter)
-9.45M-7.34M-7.94M-98.26M-4.00M-2.82M-4.38M-3.26M-3.21M-3.42M-2.81M-3.47M-3.76M-2.92M-3.93M-3.24M-2.97M-2.45M-3.28M-3.59M
Income from Continuing Operations (Quarter)
-98.53M-4.19M-2.78M-4.62M-3.65M-3.52M-53.12M-3.15M-3.85M-4.10M-53.39M-4.09M-3.39M-3.12M-58.99M-3.43M-4.03M
Consolidated Net Income (Quarter)
-98.53M-4.19M-2.78M-4.62M-3.65M-3.52M-53.12M-3.15M-3.85M-4.10M-53.39M-4.09M-3.39M-3.12M-58.99M-3.43M-4.03M
Income towards Parent Company (Quarter)
-98.53M-4.19M-2.78M-4.62M-3.65M-3.52M-53.12M-3.15M-3.85M-4.10M-53.39M-4.09M-3.39M-3.12M-58.99M-3.43M-4.03M
Net Income towards Common Stockholders (Quarter)
-98.53M-4.19M-2.78M-4.62M-3.65M-3.52M-53.12M-3.15M-3.85M-4.10M-53.39M-4.09M-3.39M-3.12M-58.99M-3.43M-4.03M
Additional items
EPS (Basic) (Quarter)
-86.96-2.42-1.68-1.42-0.98-0.94-14.68-0.75-0.65-0.69-9.69-0.68-0.56-0.49-9.02-0.23-0.27
EPS (Diluted) (Quarter)
-86.96-2.42-1.68-1.42-0.98-0.94-14.68-0.75-0.65-0.69-9.69-0.68-0.56-0.49-9.02-0.23-0.27
Shares Outstanding (Quarter)
1.06M1.06M1.10M1.13M1.73M1.66M3.26M3.73M3.74M3.62M4.20M5.94M5.94M5.51M5.99M6.08M6.37M6.54M14.69M14.69M
Shares Outstanding (Diluted) (Quarter)
1.06M1.06M1.10M1.13M1.73M1.66M3.26M3.73M3.73M3.62M4.20M5.94M5.94M5.51M5.99M6.08M6.37M6.54M14.69M14.69M
Shares Outstanding (Entity) (Quarter)
1.07M1.09M1.10M1.17M1.73M1.66M3.73M3.73M3.74M3.74M4.20M5.43M5.43M5.48M5.51M5.75M5.98M6.54M11.98M53.48M
EBITDA (Quarter)
-98.47M-4.20M-2.65M-4.62M-3.65M-3.52M-3.67M-3.15M-3.85M-4.10M-3.23M-4.09M-3.39M-3.12M-2.64M-3.43M-4.03M
Interest Expenses (Quarter)
0.06M0.06M0.12M0.06M-0.01M0.13M49.44M50.17M56.35M